Terms: = Liver cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
66 results:
1. Early hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis in a regional treatment network in Japan.
Ishimura M; Eguchi K; Sonoda M; Tanaka T; Shiraishi A; Sakai Y; Yasumi T; Miyamoto T; Voskoboinik I; Hashimoto K; Matsumoto S; Ozono S; Moritake H; Takada H; Ohga S
Int J Hematol; 2024 May; 119(5):592-602. PubMed ID: 38507116
[TBL] [Abstract] [Full Text] [Related]
2. Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma.
Tang C; Zhuang H; Tong H; Yu X; Chen J; Wang Q; Ma X; Wang B; Hua Y; Shang C; Tang Z
BMC Cancer; 2024 Jan; 24(1):137. PubMed ID: 38279090
[TBL] [Abstract] [Full Text] [Related]
3. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract] [Full Text] [Related]
4. Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment.
Guo X; Lin J; Pan L; He K; Huang Z; Chen J; Lin C; Zeng B; Luo S; Wang M
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):560-571. PubMed ID: 37850395
[TBL] [Abstract] [Full Text] [Related]
5. Interpersonal Values of Patients Participating in Phase II-III Clinical Trials: Implications for Clinical Trial Representativeness.
Gouveia R; Cruz VT; Antão J; Almeida L
Pharmaceut Med; 2023 Jul; 37(4):319-329. PubMed ID: 37249821
[TBL] [Abstract] [Full Text] [Related]
6. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
7. Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway.
Guo M; Wang W; Bai W; Bai Z; Chen W; Su Y; Wu J
Can J Gastroenterol Hepatol; 2022; 2022():6413783. PubMed ID: 36262827
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of curative effects of chemoembolization with drug-loaded microspheres of different particle sizes for the treatment of hepatocellular carcinoma].
Li Z; Ye BC; Xie RY; Wang YY; Zhang HT; Hu X; Li Y; Wu PL; Ge P; Yu BL; Wu B
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):612-617. PubMed ID: 36038322
[No Abstract] [Full Text] [Related]
9. Personalized functional profiling using
Kim H; El-Khoury V; Schulte N; Zhan T; Betge J; Cousin L; Felli E; Pessaux P; Ogier A; Opitz O; Ku B; Ebert MP; Kwon YJ
Cancer Biol Ther; 2022 Dec; 23(1):96-102. PubMed ID: 35193475
[TBL] [Abstract] [Full Text] [Related]
10. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
[TBL] [Abstract] [Full Text] [Related]
11. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
[TBL] [Abstract] [Full Text] [Related]
12. Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for treatment of liver cancer.
Cao J; Huang J; Gui S; Chu X
Int J Nanomedicine; 2021; 16():3725-3739. PubMed ID: 34103913
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Duffaud F; Italiano A; Bompas E; Rios M; Penel N; Mir O; Piperno-Neumann S; Chevreau C; Delcambre C; Bertucci F; Boudou-Rouquette P; Cancel M; Perrin C; Saada-Bouzid E; Monard L; Schiffler C; Chaigneau L; Hervieu A; Collard O; Bouvier C; Vidal V; Chabaud S; Blay JY;
Eur J Cancer; 2021 Jun; 150():108-118. PubMed ID: 33895682
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacokinetics and Catabolism of [
Bolleddula J; Shah A; Shadid M; Kamali A; Smith MD; Chowdhury SK
Drug Metab Dispos; 2020 Nov; 48(11):1239-1245. PubMed ID: 32843329
[TBL] [Abstract] [Full Text] [Related]
15. Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study.
Chiang NJ; Chen MH; Yang SH; Hsu C; Yen CJ; Tsou HH; Su YY; Chen JS; Shan YS; Chen LT
Liver Int; 2020 Oct; 40(10):2535-2543. PubMed ID: 32463975
[TBL] [Abstract] [Full Text] [Related]
16. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
17. Anterior gradient 2-derived peptide upregulates major histocompatibility complex class I-related chains A/B in hepatocellular carcinoma cells.
Bian J; He L; Wu Y; Liu W; Ma H; Sun M; Yu J; Yu Z; Wei M
Life Sci; 2020 Apr; 246():117396. PubMed ID: 32035130
[TBL] [Abstract] [Full Text] [Related]
18. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy.
Guo H; Xu M; Cao Z; Li W; Chen L; Xie X; Wang W; Liu J
Mol Pharm; 2020 Feb; 17(2):541-553. PubMed ID: 31876426
[TBL] [Abstract] [Full Text] [Related]
19. Multicentre observational cohort study of implementation and outcomes of laparoscopic distal pancreatectomy.
Lof S; Moekotte AL; Al-Sarireh B; Ammori B; Aroori S; Durkin D; Fusai GK; French JJ; Gomez D; Marangoni G; Marudanayagam R; Soonawalla Z; Sutcliffe R; White SA; Abu Hilal M;
Br J Surg; 2019 Nov; 106(12):1657-1665. PubMed ID: 31454072
[TBL] [Abstract] [Full Text] [Related]
20. HMGB1 and SEPP1 as predictors of hepatocellular carcinoma in patients with viral C hepatitis: Effect of DAAs.
Rizk NI; Sallam AM; El-Ansary AR; El-Mesallamy HO
Clin Biochem; 2019 Aug; 70():8-13. PubMed ID: 31158358
[TBL] [Abstract] [Full Text] [Related]
[Next]
